Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Emisphere Technologies, Inc. EMIS

"Emisphere Technologies Inc is a pharmaceutical and drug delivery company. It aims to partner its proprietary drug delivery technology and license its first medical food product Eligen B12, which is used to normalize vitamin B12 levels without an injection. The company is in partnership with global pharmaceutical companies to develop new oral formulations of existing injectable bio... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (OTCPK:EMIS)

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Emisphere Technologies, Inc. with Losses of $100,000 to Contact the Firm

Newsfile November 21, 2023

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Emisphere Technologies, Inc. with Losses of $100,000 to Contact the Firm

Newsfile November 20, 2023

EMIS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Emisphere Technologies, Inc Investors with Substantial Losses to Actively Participate in the Class Action Lawsuit!

Accesswire November 19, 2023

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Emisphere Technologies, Inc. with Losses of $100,000 to Contact the Firm

Newsfile November 17, 2023

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Emisphere Technologies, Inc. with Losses of $100,000 to Contact the Firm

Newsfile November 16, 2023

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Emisphere Technologies, Inc. with Losses of $100,000 to Contact the Firm

Newsfile November 15, 2023

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Emisphere Technologies, Inc. with Losses of $100,000 to Contact the Firm

Newsfile November 14, 2023

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Emisphere Technologies, Inc. with Losses of $100,000 to Contact the Firm

Newsfile November 13, 2023

EMIS Class Action Alert: Bronstein, Gewirtz & Grossman LLC Reminds Emisphere Technologies, Inc Investors with Substantial Losses to Contact the Firm!

Accesswire November 10, 2023

Opinion & Analysis (OTCPK:EMIS)

No current opinion is available.

Bullboard Posts (OTCPK:EMIS)

RE: new low $5.25

company cash $119 mm shares/out 17.8 mm cash/sh $6.68
queue - May 17, 2002

new lows

http://cbs.marketwatch.com/tools/quotes/basic.asp?symb=EMIS&sid=5847&siteid=mktw&dist=mat
queue - May 15, 2002

Proper link for story below

http://www.smallcapcenter.com/story.asp?&mb=1storytype=sccnews&component=story.asp&storyid=6726
SCCNewsServices - April 19, 2000

Stock rises after

Drug delivery specialist Emisphere Technologies Inc.?s (NASDAQ: EMIS) stock rose as much as 20% after the company said human trials...
SCCNewsServices - April 19, 2000

FYI

In the news, EMIS received a nice little blurb on January 20th in the Hambrecht and Quist 18th Annual Healthcare Conference Issue...
mhogan - January 30, 2000

emis

I believe this stock will be worth more than 100 in 2 years. Does any reason why oral heparin won't be that big?
baum - June 28, 1999